Epigral Ltd vs Privi Speciality Chemicals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 19, 2026

Key Highlights

The Latest Trading Price of Epigral Ltd is ₹ 849 as of 19 Mar 15:30 . The P/E Ratio of Epigral Ltd changed from 16 on March 2022 to 22.9 on March 2025 . This represents a CAGR of 9.38% over 4 yearsThe P/E Ratio of Privi Speciality Chemicals Ltd changed from 28.3 on March 2021 to 35.7 on March 2025 . This represents a CAGR of 4.76% over 5 years The Market Cap of Epigral Ltd changed from ₹ 4045 crore on March 2022 to ₹ 8191 crore on March 2025 . This represents a CAGR of 19.29% over 4 yearsThe Market Cap of Privi Speciality Chemicals Ltd changed from ₹ 3312 crore on March 2021 to ₹ 6669 crore on March 2025 . This represents a CAGR of 15.02% over 5 years The revenue of Epigral Ltd for the Dec '25 is ₹ 602.68 crore as compare to the Sep '25 revenue of ₹ 589.1 crore. This represent the growth of 2.31% The revenue of Privi Speciality Chemicals Ltd for the Dec '25 is ₹ 611.15 crore as compare to the Sep '25 revenue of ₹ 678.82 crore. This represent the decline of -9.97% The ebitda of Epigral Ltd for the Dec '25 is ₹ 108.26 crore as compare to the Sep '25 ebitda of ₹ 133.8 crore. This represent the decline of -19.09% The ebitda of Privi Speciality Chemicals Ltd for the Dec '25 is ₹ 157.85 crore as compare to the Sep '25 ebitda of ₹ 182.14 crore. This represent the decline of -13.34% The net profit of Epigral Ltd changed from ₹ 85.87 crore to ₹ 39.11 crore over 7 quarters. This represents a CAGR of -36.20% The net profit of Privi Speciality Chemicals Ltd changed from ₹ 31.45 crore to ₹ 74.85 crore over 7 quarters. This represents a CAGR of 64.13% The Dividend Payout of Epigral Ltd changed from 5.88 % on March 2023 to 7.26 % on March 2025 . This represents a CAGR of 7.28% over 3 yearsThe Dividend Payout of Privi Speciality Chemicals Ltd changed from 6.68 % on March 2021 to 10.32 % on March 2025 . This represents a CAGR of 9.09% over 5 years .

About Epigral Ltd

Epigral Limited was erstwhile incorporated as 'Meghmani Finechem Limited' in 2007, which is engaged in manufacturing and selling of Chlor Alkali & its Derivatives and also in Trading of Agrochemical products.
The Company was incorporated as a subsidiary of Meghmani Organics Limited. Meghmani Finechem Limited (MFL) was demerged from Meghmani Organics Limited (MOL) as a going concern, through the Scheme of Arrangement for Demerger and the said Scheme became effective from May 10, 2021.
The Chlor-Alkali business commissioned in 2009, growing from an installed capacity of 1,88,000 TPA in 2015 to 3,15,000 TPA at the close of FY 2020-21.
The Company is now among the leading players in India's chlor alkali industry.
In terms of the said Scheme, the Company allotted 2,39,03,029 Equity Shares of Rs 10/- each on 20th May, 2021 to the shareholders of Meghmani Organics Limited.

About Privi Speciality Chemicals Ltd

Privi Speciality Chemicals Limited is India's leading manufacturer, supplier, and exporter of aroma and fragrance chemicals and a globally trusted partner and supplier of bulk aroma chemicals.
The Company has in-house integrated manufacturing facilities situated at Mahad in Maharashtra and Jhagadia in Gujarat with knowledge, expertise and capacity to perform critical reactions like Hydrogenation, Condensation, Grignard reactions, as well as unit operations like Pyrolysis, Reactive Distillation, High Vacuum Distillation, Continuous Distillation to deliver consistency. Privi Speciality Chemicals Limited was initially incorporated as 'Fairchem Speciality Limited' on May 25, 1985.
The Company changed the name from Fairchem Speciality Limited to Privi Speciality Chemicals Limited on October 14, 2020.

FAQs for the comparison of Epigral Ltd and Privi Speciality Chemicals Ltd

Which company has a larger market capitalization, Epigral Ltd or Privi Speciality Chemicals Ltd?

Market cap of Epigral Ltd is 3,662 Cr while Market cap of Privi Speciality Chemicals Ltd is 11,393 Cr

What are the key factors driving the stock performance of Epigral Ltd and Privi Speciality Chemicals Ltd?

The stock performance of Epigral Ltd and Privi Speciality Chemicals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Epigral Ltd and Privi Speciality Chemicals Ltd?

As of March 19, 2026, the Epigral Ltd stock price is INR ₹849.0. On the other hand, Privi Speciality Chemicals Ltd stock price is INR ₹2916.65.

How do dividend payouts of Epigral Ltd and Privi Speciality Chemicals Ltd compare?

To compare the dividend payouts of Epigral Ltd and Privi Speciality Chemicals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.